The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

A first-of-its-kind study testing an mRNA vaccine for norovirus, the highly contagious winter vomiting bug, is launching in ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

There are currently no licenced norovirus vaccine anywhere in the world. CEO at the NIHR, Professor Lucy Chappell, added that ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...

Living a healthy lifestyle takes effort, but it’s also straightforward. Be committed. Exercise. Eat right. Avoid fads and ...

Nearly 10.4M New Yorkers, or 53%, got the flu shot last year. Only about 12% got the COVID shot. Here's why, how officials ...